Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
JZP351-502 V-RULES: Vyxeos Real-world US Long-term Effectiveness and Safety Study
Research Grant
Duke Scholars
Principal Investigator
Thomas William LeBlanc
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Jazz Pharmaceuticals
Start Date
April 24, 2024
End Date
July 30, 2025
Awarded By
Jazz Pharmaceuticals
Start Date
April 24, 2024
End Date
July 30, 2025
